Drug intelligence / Profile preview

poisonous weeds mixture

Development stage: Unknown
Lead developer: Jingning She Autonomous County Natural & Special Drugs Institute
Administration: Oral

Overview

Poisonous weeds mixture is a traditional herbal formulation currently undergoing a Phase II clinical trial for the treatment of HIV/AIDS. The Chinese name, "刹毒草合剂" (brake toxicity herbal mixture), suggests its intended therapeutic action may involve detoxification or mitigating toxicity. It is administered orally four times daily. The drug is being developed by a collaboration including Jingning She Autonomous County of Natural & Special Drugs Institute, Beijing You'an Hospital, Capital Medical University, and potentially manufactured by Zhejiang Huisong Pharmaceutical Co., Ltd.

Other names: 刹毒草合剂brake toxicity mixture

Targets

AHAS (Acetolactate synthase)ACC (Acetyl-CoA Carboxylase 1)

Beyond the preview

Go deeper on poisonous weeds mixture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on poisonous weeds mixture.

Explore the full profile